CL stock · DBD stock

CL vs DBD · P/E 34, rev $20.38B vs P/E 28, rev $3.75B

Colgate-Palmolive Company (CL) versus Diebold Nixdorf, Incorporated (DBD) — a side-by-side from cached financials, not a winner call.

Colgate-Palmolive Company (CL) is a household & personal products company listed on US.

Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.

Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.

Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.

CL currently screens at market cap $70.88B and trailing P/E 34.3. DBD currently screens at market cap $2.82B and trailing P/E 28.1.

Not investment advice. Open the CL and DBD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons